APP and Alzheimer disease: In conclusion, the present study reveals that 0.75 mg/day and 1.5 mg/day of caffeine for eight weeks is capable of reversing memory impairment in 12 month old PS1/APP transgenic mice, and BDNF and its receptor TrkB may be involved in the protective role of caffeine against memory impairment in AD.